Tag Archives: AMONG

Self-stigma, especially around substance use, impedes HIV self-care among gay and bisexual men living with HIV who use drugs

A qualitative study sought to understand how internalised stigma affects HIV self-care among gay and bisexual men living with HIV who use substances. Men in this cohort experienced self-stigma stemming from multiple intersecting identities, including their HIV status, sexual orientation, race, effeminateness, poverty, and housing instability. Self-stigma around drug use was reported as the most… Read More »

#FierceMadness pharma ad contest narrows: Pfizer, Bayer, Novartis, ViiV and Biohaven among the Elite Eight still standing

FierceMadess voters have spoken—and now, just an Elite Eight pharma advertisers are still in the running for the 2021 title. Pfizer, Bayer, Novartis, Roche, Johnson & Johnson and GlaxoSmithKline’s ViiV Healthcare are among the Big Pharma contenders still playing in the DTC ad campaign contest, while Evofem Biosciences and Biohaven Pharmaceuticals are the smaller upstarts looking for… Read More »

It’s possible to end HIV epidemics among people who inject drugs in low- and middle-income countries

HIV incidence is below 0.1% per year among people who inject drugs in a large Vietnamese city, Professor Don Des Jarlais and colleagues report in the December issue of AIDS. They say the data clearly demonstrate that it is possible to achieve very low HIV incidence – ‘to end an HIV epidemic’ – among people… Read More »

New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime – BioSpace

ORLANDO, Fla., Jan. 6, 2020 /PRNewswire/ — AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the U.S., is pleased to include Trikafta® (elexacaftor/tezacaftor/ivacaftor and ivacaftor), a new breakthrough therapy for cystic fibrosis (CF), among other specialty medications available through its pharmacy. Cystic fibrosis is a rare, progressive, life-threatening disease… Read More »

Outbreak of virulent recombinant HIV strain reported among gay men in Paris region

Public health officials in France have reported an outbreak of a recombinant strain of HIV characterised by a high viral load during early infection and rapid loss of CD4 cells. The outbreak involved X4 tropic virus, usually associated with more advanced HIV, and is reported in Eurosurveillance by a team led by Dr Marc Wirden… Read More »